# Magnesium and Dexmedetomidine in Pheochromocytoma

> **NCT05102058** · — · COMPLETED · sponsor: **Istanbul University** · enrollment: 108 (actual)

## Conditions studied

- Phaeochromocytoma Crisis
- Hemodynamic Instability

## Interventions

- **DRUG:** Magnesium-Dexmedetomidine

## Key facts

- **NCT ID:** NCT05102058
- **Lead sponsor:** Istanbul University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05102058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05102058, "Magnesium and Dexmedetomidine in Pheochromocytoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05102058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*